MyFinsight
Home
About
Contact
sndx: the income statement
Download
Download image
Net loss
-$60,715K
(27.83%↑ Y/Y)
Collaboration Revenue
$13,864K
Product
$32,007K
Total other (expense)
income, net
-$3,289K
(-160.34%↓ Y/Y)
Loss from operations
-$57,426K
(35.89%↑ Y/Y)
Interest income
$5,269K
(-3.18%↓ Y/Y)
Total revenues
$45,871K
(266.97%↑ Y/Y)
Other (expense)
income
-$275K
(-959.38%↓ Y/Y)
Royalty interest
expense
$8,283K
Total operating
expenses
$103,297K
(1.20%↑ Y/Y)
Selling, general and
administrative
$44,917K
(44.40%↑ Y/Y)
Research and development
$56,280K
(-20.70%↓ Y/Y)
Cost of product sales
$2,100K
Back
Back
Income Statement
source: myfinsight.com
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)